ARCOSA INC (ACA) Stock Fundamental Analysis
USA - NYSE:ACA - US0396531008 - Common Stock
99.58 USD
+1.11 (+1.13%)
We assign a fundamental rating of 5 out of 10 to ACA. ACA was compared to 55 industry peers in the Construction & Engineering industry. ACA has only an average score on both its financial health and profitability. ACA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ACA had positive earnings in the past year.
ACA had a positive operating cash flow in the past year.
Each year in the past 5 years ACA has been profitable.
Each year in the past 5 years ACA had a positive operating cash flow.
1.2 Ratios
ACA has a Return On Assets (2.94%) which is comparable to the rest of the industry.
ACA has a Return On Equity of 5.75%. This is comparable to the rest of the industry: ACA outperforms 43.64% of its industry peers.
ACA has a Return On Invested Capital (4.99%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ACA is significantly below the industry average of 16.87%.
The 3 year average ROIC (3.99%) for ACA is below the current ROIC(4.99%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROIC | 4.99% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
1.3 Margins
ACA has a Profit Margin of 5.25%. This is in the better half of the industry: ACA outperforms 67.27% of its industry peers.
In the last couple of years the Profit Margin of ACA has declined.
ACA has a better Operating Margin (10.27%) than 74.55% of its industry peers.
In the last couple of years the Operating Margin of ACA has declined.
ACA's Gross Margin of 21.61% is fine compared to the rest of the industry. ACA outperforms 63.64% of its industry peers.
In the last couple of years the Gross Margin of ACA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% |
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACA is destroying value.
ACA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACA has more shares outstanding
The debt/assets ratio for ACA is higher compared to a year ago.
2.2 Solvency
ACA has an Altman-Z score of 2.31. This is not the best score and indicates that ACA is in the grey zone with still only limited risk for bankruptcy at the moment.
ACA has a Altman-Z score of 2.31. This is comparable to the rest of the industry: ACA outperforms 45.45% of its industry peers.
The Debt to FCF ratio of ACA is 5.03, which is a neutral value as it means it would take ACA, 5.03 years of fcf income to pay off all of its debts.
ACA has a better Debt to FCF ratio (5.03) than 61.82% of its industry peers.
A Debt/Equity ratio of 0.61 indicates that ACA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.61, ACA perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Altman-Z | 2.31 |
ROIC/WACC0.51
WACC9.8%
2.3 Liquidity
ACA has a Current Ratio of 2.02. This indicates that ACA is financially healthy and has no problem in meeting its short term obligations.
ACA has a Current ratio of 2.02. This is amongst the best in the industry. ACA outperforms 89.09% of its industry peers.
ACA has a Quick Ratio of 1.30. This is a normal value and indicates that ACA is financially healthy and should not expect problems in meeting its short term obligations.
ACA has a Quick ratio of 1.30. This is comparable to the rest of the industry: ACA outperforms 58.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
ACA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.03%, which is quite good.
Measured over the past 5 years, ACA shows a small growth in Earnings Per Share. The EPS has been growing by 5.16% on average per year.
ACA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.96%.
ACA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.15% yearly.
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
3.2 Future
The Earnings Per Share is expected to grow by 20.31% on average over the next years. This is a very strong growth
Based on estimates for the next years, ACA will show a small growth in Revenue. The Revenue will grow by 7.30% on average per year.
EPS Next Y36.06%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
EPS Next 5YN/A
Revenue Next Year10.62%
Revenue Next 2Y8.3%
Revenue Next 3Y7.3%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 26.34, ACA can be considered very expensive at the moment.
ACA's Price/Earnings ratio is a bit cheaper when compared to the industry. ACA is cheaper than 70.91% of the companies in the same industry.
When comparing the Price/Earnings ratio of ACA to the average of the S&P500 Index (25.51), we can say ACA is valued inline with the index average.
ACA is valuated rather expensively with a Price/Forward Earnings ratio of 21.20.
74.55% of the companies in the same industry are more expensive than ACA, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ACA to the average of the S&P500 Index (34.98), we can say ACA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.34 | ||
| Fwd PE | 21.2 |
4.2 Price Multiples
ACA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACA is cheaper than 83.64% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ACA is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.52 | ||
| EV/EBITDA | 11.97 |
4.3 Compensation for Growth
ACA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ACA's earnings are expected to grow with 20.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)5.1
EPS Next 2Y24.91%
EPS Next 3Y20.31%
5. Dividend
5.1 Amount
ACA has a yearly dividend return of 0.20%, which is pretty low.
ACA's Dividend Yield is rather good when compared to the industry average which is at 1.76. ACA pays more dividend than 81.82% of the companies in the same industry.
With a Dividend Yield of 0.20, ACA pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
5.2 History
The dividend of ACA decreases each year by -0.48%.
ACA has been paying a dividend for over 5 years, so it has already some track record.
As ACA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
5.3 Sustainability
6.66% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
DP6.66%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
NYSE:ACA (11/19/2025, 1:20:51 PM)
99.58
+1.11 (+1.13%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners95.34%
Inst Owner Change-4.39%
Ins Owners1.8%
Ins Owner Change-2.15%
Market Cap4.88B
Revenue(TTM)2.83B
Net Income(TTM)148.60M
Analysts86
Price Target118.32 (18.82%)
Short Float %2.41%
Short Ratio5.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)0%
PT rev (3m)3.73%
EPS NQ rev (1m)0.74%
EPS NQ rev (3m)-1.09%
EPS NY rev (1m)1.84%
EPS NY rev (3m)6.43%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)-0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.34 | ||
| Fwd PE | 21.2 | ||
| P/S | 1.72 | ||
| P/FCF | 15.52 | ||
| P/OCF | 10.41 | ||
| P/B | 1.89 | ||
| P/tB | 5.32 | ||
| EV/EBITDA | 11.97 |
EPS(TTM)3.78
EY3.8%
EPS(NY)4.7
Fwd EY4.72%
FCF(TTM)6.42
FCFY6.44%
OCF(TTM)9.57
OCFY9.61%
SpS57.77
BVpS52.71
TBVpS18.73
PEG (NY)0.73
PEG (5Y)5.1
Graham Number66.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROCE | 6.5% | ||
| ROIC | 4.99% | ||
| ROICexc | 5.24% | ||
| ROICexgc | 8.62% | ||
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% | ||
| FCFM | 11.11% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Debt/EBITDA | 3.04 | ||
| Cap/Depr | 68.36% | ||
| Cap/Sales | 5.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.74% | ||
| Profit Quality | 211.71% | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 2.31 |
F-Score5
WACC9.8%
ROIC/WACC0.51
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
EPS Next Y36.06%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
Revenue Next Year10.62%
Revenue Next 2Y8.3%
Revenue Next 3Y7.3%
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year133.35%
EBIT Next 3Y37.6%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%
ARCOSA INC / ACA FAQ
Can you provide the ChartMill fundamental rating for ARCOSA INC?
ChartMill assigns a fundamental rating of 5 / 10 to ACA.
What is the valuation status for ACA stock?
ChartMill assigns a valuation rating of 6 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.
Can you provide the profitability details for ARCOSA INC?
ARCOSA INC (ACA) has a profitability rating of 5 / 10.
What are the PE and PB ratios of ARCOSA INC (ACA) stock?
The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 26.34 and the Price/Book (PB) ratio is 1.89.
What is the expected EPS growth for ARCOSA INC (ACA) stock?
The Earnings per Share (EPS) of ARCOSA INC (ACA) is expected to grow by 36.06% in the next year.